|本期目录/Table of Contents|

[1]王天宇 综述,于向阳 审校.JMJD3在胃肠道肿瘤中的研究进展[J].天津医科大学学报,2024,30(05):476-488.[doi:10.20135/j.issn.1006-8147.2024.05.0476]
点击复制

JMJD3在胃肠道肿瘤中的研究进展(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
30卷
期数:
2024年05期
页码:
476-488
栏目:
综述
出版日期:
2024-09-25

文章信息/Info

Title:
-
文章编号:
1006-8147（2024）05-0476-04
作者:
王天宇1 综述; 于向阳2 审校
（1.天津医科大学南开临床学院，天津 300070；2.天津市南开医院胃肠外科，天津 300110）
Author(s):
-
关键词:
JMJD3; 胃肠道肿瘤; 表观遗传修饰; 去甲基化
Keywords:
-
分类号:
R735
DOI:
10.20135/j.issn.1006-8147.2024.05.0476
文献标志码:
A
摘要:
JMJD3是与肿瘤发生和发展密切相关的表观遗传修饰酶。JMJD3在胃肠道肿瘤中的表达水平存在差异，并且与患者的临床特征和预后密切相关。JMJD3通过调节肿瘤细胞的增殖、转移和侵袭等生物学行为，在胃肠道肿瘤的发生和发展中起重要作用。JMJD3可能通过调节胃肠道肿瘤干细胞特性、肿瘤免疫微环境，影响肿瘤对治疗的反应和耐药性。因此，JMJD3被认为是胃肠道肿瘤的潜在治疗靶点，针对JMJD3的治疗策略可能为胃肠道肿瘤治疗提供新的思路和方法。
Abstract:
-

参考文献/References:

[1] SUNG H，FERLAY J，SIEGEL R L，et al. Global cancer statistics 2020：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin，2021，71（3）：209-249.
[2] AL ZEIN M，BOUKHDOUD M，SHAMMAA H，et al. Immunotherapy and immunoevasion of colorectal cancer[J]. Drug Discovery Today，2023，28（9）：103669.
[3] SANCHEZ A，HOUFAF KHOUFAF F Z，IDRISSOU M，et al. The functions of the demethylase JMJD3 in cancer[J].Int J Mol Sci，2021，22（2）：968.
[4] FARZANEH M，KUCHAKI Z，RASHID SHEYKHAHMAD F，et al. Emerging roles of JMJD3 in cancer[J]. Clin Transl Oncol，2022，24（7）：1238-1249.
[5] ZHANG X，LIU L，YUAN X，et al. JMJD3 in the regulation of human diseases[J].Protein Cell，2019，10（12）：864-882.
[6] LAGUNAS-RANGEL F A. KDM6B（JMJD3） and its dual role in cancer[J]. Biochimie，2021，184：63-71.
[7] WANG S，WANG Y，ZHU H，et al. Expression pattern of histone lysine-specific demethylase 6B in gastric cancer[J]. Oncol Lett，2021， 21（6）：491.
[8] XU Z，XIA Y，XIAO Z，et al. Comprehensive profiling of JMJD3 in gastric cancer and its influence on patient survival[J]. Sci Rep，2019， 9（1）：868.
[9] TOKUNAGA R，SAKAMOTO Y，NAKAGAWA S，et al. The prognostic significance of histone lysine demethylase JMJD3/KDM6B in colorectal cancer [J]. Ann Surg Oncol，2016，23（2）：678-685.
[10] PEREIRA F，BARB?魣CHANO A，SILVA J，et al. KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells[J].Hum Mol Genet，2011，20（23）：4655-4665.
[11] LIN C W，LIAO M Y，LIN W W，et al. Epithelial cell adhesion molecule regulates tumor initiation and tumorigenesis via activating reprogramming factors and epithelial-mesenchymal transition gene expression in colon cancer[J]. J Biol Chem，2012，287（47）：39449-39459.
[12] LIAO M Y，KUO M Y P，LU T Y，et al. Generation of an anti-EpCAM antibody and epigenetic regulation of EpCAM in colorectal cancer[J]. Int J Oncol，2015，46（4）：1788-1800.
[13] PROPPER D J，BALKWILL F R. Harnessing cytokines and chemo-kines for cancer therapy[J]. Nat Rev Clin Oncol，2022，19（4）：237-253.
[14] ZOU S，ZHANG D，XU Z，et al. JMJD3 promotes the epithelial-mesenchymal transition and migration of glioma cells via the CXCL12/CXCR4 axis[J]. Oncol Lett，2019，18（6）：5930-5940.
[15] BOCCHI M，DE SOUSA PEREIRA N，DE OLIVEIRA K B，et al. Involvement of CXCL12/CXCR4 axis in colorectal cancer：a mini-review[J]. Mol Biol Rep，2023，50（7）：6233-6239.
[16] OGAWA M，WATANABE M，HASEGAWA T，et al. Expression of CXCR-4 and IDO in human colorectal cancer：an immunohistochemical approach[J]. Mol Clin Oncol，2017，6（5）：701-704.
[17] LIU F，WANG Y，YANG Z，et al. KDM6B promotes gastric carcinogenesis and metastasis via upregulation of CXCR4 expression[J].Cell Death Dis，2022，13（12）：1068.
[18] CAO Y，JIAO N，SUN T，et al. CXCL11 correlates with antitumor immunity and an improved prognosis in colon cancer[J]. Front Cell Dev Biol，2021，9：646252.
[19] NAGARSHETH N，PENG D，KRYCZEK I，et al. PRC2 epigenetically silences Th1-type chemokines to suppress effector T-cell trafficking in colon cancer[J]. Cancer Res，2016，76（2）：275-282.
[20] XU B，DENG C，WU X，et al. CCR9 and CCL25：a review of their roles in tumor promotion[J]. J Cell Physiol，2020，235（12）：9121-9132.
[21] ZHANG H，HU Y，LIU D，et al. The histone demethylase KDM6B regulates the maturation and cytotoxicity of TCRαβ+CD8αα+ intestinal intraepithelial lymphocytes[J]. Cell Death Differ，2022，29（7）：1349-1363.
[22] FERREIRA A，ASTER J C. Notch signaling in cancer：complexity and challenges on the path to clinical translation[J].Semin Cancer Biol，2022，85：95-106.
[23] LIAN H，JIA X，SHI N，et al. Notch signaling promotes serrated neoplasia pathway in colorectal cancer through epigenetic modification of EPHB2 and EPHB4[J]. Cancer Manage Res，2018，10：6129-6141.
[24] WANG Q，CHEN X，JIANG Y，et al. Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin[J]. J Mol Cell Biol，2020， 12（2）：125-137.
[25] ZHANG G，XU Y，ZOU C，et al. Long noncoding RNA ARHGA-P27P1 inhibits gastric cancer cell proliferation and cell cycle progression through epigenetically regulating p15 and p16[J]. Aging，2019，11（20）：9090-9110.
[26] JANICZEK-POLEWSKA M，SZYLBERG ?覵，MALICKI J，et al. Role of interleukins and new perspectives in mechanisms of resistance to chemotherapy in gastric cancer[J]. Biomedicines，2022，10（7）：1600.
[27] GUO Z，ZHANG S，LIU X，et al. Design，synthesis，and evaluation of JTE-013 derivatives as novel potent S1PR2 antagonists for recovering the sensitivity of colorectal cancer to 5-fluorouracil[J].Bioorg Chem，2023，131：106318.
[28] HUANG H，TSUI Y M，NGIO L. Fueling HCC dynamics：interplay between tumor microenvironment and tumor initiating cells[J].Cell Mol Gastroenterol Hepatol，2023，15（5）：1105-1116.
[29] ZHANG J，YING Y，LI M，et al. Targeted inhibition of KDM6 histone demethylases eradicates tumor-initiating cells via enhancer reprogramming in colorectal cancer[J]. Theranostics，2020，10（22）：10016-10030.
[30] QU Y，WU Y，JIANG H. Research progress in the pharmacological actions of the multiple effects and selectivity of the vitamin D analogue paricalcitol：a narrative review[J].Ann Surg Oncol，2021，10（10）：11177-11190.
[31] XUN J，WANG D，SHEN L，et al. JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity[J]. Oncotarget，2017，8（13）：21918-21929.
[32] ASLAM A，AHMAD J，BAGHDADI M A，et al. Chemopreventive effects of vitamin D3 and its analogue，paricalcitol，in combination with 5-fluorouracil against colorectal cancer：the role of calcium signalling molecules[J]. Biochim Biophys Acta，Mol Basis Dis，2021， 1867（3）：166040.

相似文献/References:

备注/Memo

备注/Memo:
作者简介 王天宇（1998-），男，医师，硕士，研究方向：外科学；通信作者：于向阳，E-mail：yxynankai@126.com。
更新日期/Last Update: 2024-09-20